Story thread · 2 reports / 2 sources
This Biotech Stock Just Gapped Up To A Five-Year High; Here's Why
investors.com · 1h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
Omeros stock rocketed to a five-year high Thursday on blowout second-quarter results for its new treatment for transplant complications. The post This Biotech Stock Just Gapped Up To A Five-Year High; Here's Why appeared first on Investor's Business Daily .
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.